Basic Information
VYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML
INFUSION, SOLUTION CONCENTRATE
Regulatory Information
SIN16325P
September 16, 2021
Prescription Only
Therapeutic
INTRAVENOUS DRIP
August 10, 2023
June 3, 2025
XN02CD05
Company Information
Active Ingredients
EPTINEZUMAB
Strength: 100 MG/ML
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 3.2 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**4.1 Therapeutic indications** VYEPTI is indicated for prophylaxis of migraine in adults.